| Literature DB >> 33678552 |
Amir Iravani1, Catherine Mitchell2, Tim Akhurst3, Shahneen Sandhu4, Michael S Hofman3, Rodney J Hicks3.
Abstract
Entities:
Keywords: Fluorodeoxyglucose; Neuroedocrine differentiation of prostate cancer; Prostate-specific membrane antigen; Radionuclide therapy; Somatostatin receptor
Year: 2021 PMID: 33678552 DOI: 10.1016/j.clgc.2021.01.008
Source DB: PubMed Journal: Clin Genitourin Cancer ISSN: 1558-7673 Impact factor: 2.872